Janux Therapeutics, Inc. Company Information
Janux Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Janux Therapeutics, Inc.
- Ticker: JANX
- Exchange: NasdaqGM
- Founded: 2017
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$2.562b
- Shares Outstanding: 52.48m
- Website: https://www.januxrx.com
Number of Employees
Location
- Janux Therapeutics, Inc.
- 10955 Vista Sorrento Parkway
- Suite 200
- San Diego
- California
- 92130
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| JANX | NasdaqGM (Nasdaq Global Market) | Yes | Common Stock | US | USD | Jun 2021 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/26 21:21 |
| End of Day Share Price | 2024/11/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.